Asthma genetics

Respiratory Genetics

Volumn , Issue , 2005, Pages 219-251

  Celedon, Juan C ^a   Raby, Benjamin A ^a   Weiss, Scott T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845795779     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13341-61     Document Type: Chapter

References (403)

1. Elias JA, Lee CG, Zheng T et al. New insights into the pathogenesis of asthma. J Clin Invest 2003; 111: 291-7.
2. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-36.
3. Yunginger JW, Reed CE, O’Connell EJ et al. A community-based study of the epidemiology of asthm. Incidence rates, 1964-1983. Am Rev Respir Dis 1992; 146: 888-94.
4. Mannino DM, Homa DM, Akinbami LJ et al. Surveillance for asthma - United States, 1980-1999. MMWR Surveill Summ 2002; 51: 1-13.
5. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001; 107: 3-8.
6. Davis EC, Mecham RP. Selective degradation of accumulated secretory proteins in the endoplasmic reticulum. A possible clearance pathway for abnormal tropoelastin. J Biol Chem 1996; 271: 3787-94.
7. Grimbacher B, Holland SM, Gallin JI et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N Engl J Med 1999; 340: 692-702.
8. Daumling S, Buriot D, Trung PH et al. The Buckley syndrome: recurring, severe staphylococcal infections, eczema and hyperimmunoglobulinemia E (author’s translation). Infection 1980; 8 (Suppl 3): 248-54.
9. Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrentinfection (Job’s) syndrome. A review of the NIH experience and the literature. Medicine (Balt) 1983; 62: 195-208.
10. Belohradsky BH, Daumling S, Kiess W, Griscelli C. The hyper-IgEsyndrome (Buckley- or Job-syndrome). Ergeb Inn Med Kinderheilkd 1987; 55: 1-39.
11. Gahr M, Muller W, Allgeier B, Speer CP. A boy with recurrent infections, impaired PMN-chemotaxis, increased IgE concentrations and cranial synostosis - a variant of the hyper-IgE syndrome? Helv Paediatr Acta 1987; 42: 185-90.
12. Buckley RH, Becker WG. Abnormalities in the regulation of human IgE synthesis. Immunol Rev 1978; 41: 288-314.
13. Leung DY, Frankel R, Wood N, Geha RS. Potentiation of human immunoglobulin E synthesis by plasma immunoglobulin E binding factors from patients with the hyperimmunoglobulin E syndrome. J Clin Invest 1986; 77: 952-7.
14. Geha RS, Leung DY. Regulation of the human allergic response. Int Arch Allergy Appl Immunol 1987; 82: 389-91.
15. Van Scoy RE, Hill HR, Ritts RE, Quie PG. Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E. Ann Intern Med 1975; 82: 766-71.
16. Robinson MF, McGregor R, Collins R, Cheung K. Combined neutrophil and T-cell deficiency: initial report of a kindred with features of the hyper-IgE syndrome and chronic granulomatous disease. Am J Med 1982; 73: 63-70.
17. Hill HR, Quie PG. Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1974; 1: 183-7.
18. Witemeyer S, Van Epps DE. A familial defect in cellular chemotaxis associated with redheadedness and recurrent infection. J Pediatr 1976; 89: 33-7.
19. Donabedian H, Gallin JI. Mononuclear cells from patients with the hyperimmunoglobulin E-recurrent infection syndrome produce an inhibitor of leukocyte chemotaxis. J Clin Invest 1982; 69: 1155-63.
20. Ito S, Shinomiya K, Mikawa H. Suppressive effect of IgE soluble immune complex on neutrophil chemotaxis. Clin Exp Immunol 1983; 51: 407-12.
21. Quinti I, Brozek C, Wood N et al. Circulating IgG autoantibodies to IgE in atopic syndromes. J Allergy Clin Immunol 1986; 77: 586-94.
22. Geha RS, Reinherz E, Leung D et al. Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome. J Clin Invest 1981; 68: 783-91.
23. King CL, Gallin JI, Malech HL et al. Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci USA 1989; 86: 10085-9.
24. Paganelli R, Scala E, Capobianchi MR et al. Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis. Clin Exp Immunol 1991; 84: 28-33.
25. Rousset F, Robert J, Andary M et al. Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol 1991; 87: 58-69.
26. Claasen JJ, Levine AD, Schiff SE, Buckley RH. Mononuclear cells from patients with the hyper-IgE syndrome produce little IgE when they are stimulated with recombinant human interleukin-4. J Allergy Clin Immunol 1991; 88: 713-21.
27. Grimbacher B, Dutra AS, Holland SM et al. Analphoid marker chromosome in a patient with hyper-IgE syndrome, autism, and mild mental retardation. Genet Med 1999; 1: 213-8.
28. Grimbacher B, Schaffer AA, Holland SM et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet 1999; 65: 735-44.
29. Hershey GK, Friedrich MF, Esswein LA et al. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997; 337: 1720-5.
30. Grimbacher B, Holland SM, Puck JM. The interleukin-4 receptor variant Q576R in hyper-IgE syndrome. N Engl J Med 1998; 338: 1073-4.
31. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Balt) 1975; 54: 1-27.
32. Kao CC, Ou LS, Lin SJ, Huang JL. Childhood idiopathic hypereosinophilic syndrome: report of a case. Asian Pac J Allergy Immunol 2002; 20: 121-6.
33. Marshall GM, White L. Effective therapy for a severe case of the idiopathic hypereosinophilic syndrome. Am J Pediatr Hematol Oncol 1989; 11: 178-83.
34. Klion AD, Law MA, Riemenschneider W et al. Familial eosinophilia: a benign disorder? Blood 2004; 103: 4050-5.
35. Lefebvre C, Bletry O, Degoulet P et al. Prognostic factors of hypereosinophilic syndrome. Study of 40 cases. Ann Med Interne (Paris) 1989; 140: 253-7.
36. Cools J, DeAngelo DJ, Gotlib J et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201-14.
37. Klion AD, Law MA, Noel P et al. Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood 2004; 103: 2939-41.
38. Stone RM, Gilliland DG, Klion AD. Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome. Semin Oncol 2004; 31: 12-7.
39. Luppi M, Marasca R, Morselli M et al. Clonal nature of hypereosinophilic syndrome. Blood 1994; 84: 349-50.
40. Chang HW, Leong KH, Koh DR, Lee SH. Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood 1999; 93: 1651-7.
41. Weinfeld A, Westin J, Swolin B. Ph1-negative eosinophilic leukaemia with trisomy 8. Case report and review of cytogenetic studies. Scand J Haematol 1977; 18: 413-20.
42. Guitard AM, Horschowski N, Mozziconacci MJ et al. Hypereosinophilic syndrome in childhood: trisomy 8 and transformation to mixed acute leukaemia. Nouv Rev Fr Hematol 1994; 35: 555-9.
43. Quiquandon I, Claisse JF, Capiod JC et al. alpha-Interferon and hypereosinophilic syndrome with trisomy 8: karyotypic remission. Blood 1995; 85: 2284-5.
44. Myint H, Chacko J, Mould S et al. Karyotypic evolution in a granulocytic sarcoma developing in a myeloproliferative disorder with a novel (3;4) translocation. Br J Haematol 1995; 90: 462-4.
45. Duell T, Mittermuller J, Schmetzer HM et al. Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32). Cancer Genet Cytogenet 1997; 94: 91-4.
46. Jost E, Michaux L, Vanden Abeele M et al. Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage. Ann Hematol 2001; 80: 302-7.
47. Carroll M, Ohno-Jones S, Tamura S et al. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood 1997; 90: 4947-52.
48. Buchdunger E, Cioffi CL, Law N et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295: 139-45.
49. Gotlib J, Cools J, Malone JM 3rd et al. The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 2004; 103: 2879-91.
50. Klion AD, Noel P, Akin C et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 2003; 101: 4660-6.
51. Klion AD, Robyn J, Akin C et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 2004; 103: 473-8.
52. Pardanani A, Brockman SR, Paternoster SF et al. FIP1L1-PDGFRA fusion: Prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 2004; 104: 3038-45.
53. Naiman JL, Oski FA, Allen FH Jr, Diamond LK. Hereditary eosinophilia: Report of a family and review of the literature. Am J Hum Genet 1964; 16: 195-203.
54. Zeni G, Nardi F, Frezza M. In tema di ipereosinofilia constituzionale familiare idiopatica. Acta Med Patav 1964; 24: 589-602.
55. Zuelzer WW, Apt L. Disseminated visceral lesions associated with extreme eosinophilia: pathological and clinical observations on syndrome of young children. Am J Dis Child 1949; 78: 153-81.
56. Sparrevohn S. Disseminated eosinophilic collagenosis and familial eosinophilia. Acta Paediatr Scand 1967; 56: 307-12.
57. Lin AY, Nutman TB, Kaslow D et al. Familial eosinophilia: clinical and laboratory results on a US kindred. Am J Med Genet 1998; 76: 229-37.
58. Rioux JD, Stone VA, Daly MJ et al. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet 1998; 63: 1086-94.
59. Haagerup A, Bjerke T, Schiotz PO et al. Asthma and atopy - a total genome scan for susceptibility genes. Allergy 2002; 57: 680-6.
60. Koppelman GH, Stine OC, Xu J et al. Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol 2002; 109: 498-506.
61. Yokouchi Y, Nukaga Y, Shibasaki M et al. Significant evidence for linkage of mite-sensitive childhood asthma to chromosome 5q31-q33 near the interleukin 12 B locus by a genome-wide search in Japanese families. Genomics 2000; 66: 152-60.
62. Akin C, Metcalfe DD. Systemic mastocytosis. Annu Rev Med 2004; 55: 419-32.
63. Parker RI. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease. J Invest Dermatol 1991; 96: 47S-51S.
64. Akin C, Jaffe ES, Raffeld M et al. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells. Am J Clin Pathol 2002; 118: 242-7.
65. Schwartz LB, Sakai K, Bradford TR et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995; 96: 2702-10.
66. Escribano L, Orfao A, Diaz-Agustin B et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 1998; 91: 2731-6.
67. Burgoon CF Jr, Graham JH, McCaffree DL. Mast cell disease. A cutaneous variant with multisystem involvement. Arch Dermatol 1968; 98: 590-605.
68. Selmanowitz VJ, Orentreich N. Mastocytosis. A clinical genetic evaluation. J Hered 1970; 61: 91-4.
69. Shaw JM. Genetic aspects of urticaria pigmentosa. Arch Dermatol 1968; 97: 137-8.
70. Boyano T, Carrascosa T, Val J et al. Urticaria pigmentosa in monozygotic twins. Arch Dermatol 1990; 126: 1375-6.
71. Clark DP, Buescher L, Havey A. Familial urticaria pigmentosa. Arch Intern Med 1990; 150: 1742-4.
72. Anstey A, Lowe DG, Kirby JD, Horton MA. Familial mastocytosis: a clinical, immunophenotypic, light and electron microscopic study. Br J Dermatol 1991; 125: 583-7.
73. James MP, Eady RA. Familial urticaria pigmentosa with giant mast cell granules. A clinical, light, and electron microscopic study. Arch Dermatol 1981; 117: 713-8.
74. Sundstrom M, Vliagoftis H, Karlberg P et al. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene. Immunology 2003; 108: 89-97.
75. Beghini A, Ripamonti CB, Castorina P et al. Trisomy 4 leading to duplication of a mutated KIT allele in acute myeloid leukemia with mast cell involvement. Cancer Genet Cytogenet 2000; 119: 26-31.
76. Lishner M, Confino-Cohen R, Mekori YA et al. Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. J Allergy Clin Immunol 1996; 98: 199-204.
77. Sillaber C, Strobl H, Bevec D et al. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 1991; 147: 4224-8.
78. Galli SJ, Kitamura Y. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol 1987; 127: 191-8.
79. Nagata H, Worobec AS, Oh CK et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560-4.
80. Longley BJ Jr, Metcalfe DD, Tharp M et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999; 96: 1609-14.
81. Akin C, Kirshenbaum AS, Semere T et al. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp Hematol 2000; 28: 140-7.
82. Akin C, Fumo G, Yavuz AS et al. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 2004; 103: 3222-5.
83. Pignon JM, Giraudier S, Duquesnoy P et al. A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 1997; 96: 374-6.
84. Worobec AS, Semere T, Nagata H, Metcalfe DD. Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer 1998; 83: 2120-9.
85. Fritsche-Polanz R, Jordan JH, Feix A et al. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol 2001; 113: 357-64.
86. Rosbotham JL, Malik NM, Syrris P et al. Lack of c-kit mutation in familial urticaria pigmentosa. Br J Dermatol 1999; 140: 849-52.
87. Tang X, Boxer M, Drummond A et al. A germline mutation in KIT in familial diffuse cutaneous mastocytosis. J Med Genet 2004; 41: e88.
88. Akin C, Brockow K, D’Ambrosio C et al. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. Exp Hematol 2003; 31: 686-92.
89. Netherton EW. A unique case of trichorrhexis nodosa; bamboo hairs. AMA Arch Derm 1958; 78: 483-7.
90. Altman J, Stroud J. Netherton’s syndrome and ichthyosis linearis circumflexa. Arch Dermatol 1969; 100: 550-8.
91. Julius CE, Keeran M. Netherton’s syndrome in a male. Arch Dermatol 1971; 104: 422-4.
92. Smith DL, Smith JG, Wong SW, deShazo RD. Netherton’s syndrome: a syndrome of elevated IgE and characteristic skin and hair findings. J Allergy Clin Immunol 1995; 95: 116-23.
93. Chavanas S, Garner C, Bodemer C et al. Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Hum Genet 2000; 66: 914-21.
94. Chavanas S, Bodemer C, Rochat A et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25: 141-2.
95. Magert HJ, Standker L, Kreutzmann P et al. LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem 1999; 274: 21499-502.
96. Walley AJ, Chavanas S, Moffatt MF et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001; 29: 175-8.
97. Kato A, Fukai K, Oiso N et al. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 2003; 148: 665-9.
98. Nishio Y, Noguchi E, Shibasaki M et al. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun 2003; 4: 515-7.
99. Kabesch M, Carr D, Weiland SK, von Mutius E. Association between polymorphisms in serine protease inhibitor, kazal type 5 and asthma phenotypes in a large German population sample. Clin Exp Allergy 2004; 34: 340-5.
100. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27: 277-301.
101. Finan MC, Winkelmann RK. The cutaneous extravascular necrotizing granuloma (Churg-Strauss granuloma) and systemic disease: a review of 27 cases. Medicine (Balt) 1983; 62: 142-58.
102. Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100.
103. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
104. Guillevin L, Cohen P, Gayraud M et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Balt) 1999; 78: 26-37.
105. Wechsler ME, Finn D, Gunawardena D et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000; 117: 708-13.
106. Martin RM, Wilton LV, Mann RD. Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf 1999; 8: 179-89.
107. Wechsler ME, Garpestad E, Flier SR et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. J Am Med Assoc 1998; 279: 455-7.
108. Le Gall C, Pham S, Vignes S et al. Inhaled corticosteroids and Churg-Strauss syndrome: a report of five cases. Eur Respir J 2000; 15: 978-81.
109. Churg A, Brallas M, Cronin SR, Churg J. Formes frustes of Churg-Strauss syndrome. Chest 1995; 108: 320-3.
110. Schmitt WH, Csernok E, Kobayashi S et al. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum 1998; 41: 445-52.
111. Schonermarck U, Csernok E, Trabandt A et al. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCAassociated vasculitides. Clin Exp Rheumatol 2000; 18: 457-63.
112. Kiene M, Csernok E, Muller A et al. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum 2001; 44: 469-73.
113. Muschen M, Warskulat U, Perniok A et al. Involvement of soluble CD95 in Churg-Strauss syndrome. Am J Pathol 1999; 155: 915-25.
114. Manganelli P, Giacosa R, Fietta P et al. Familial vasculitides: Churg-Strauss syndrome and Wegener’s granulomatosis in two first-degree relatives. J Rheumatol 2003; 30: 618-21.
115. Steffensen FH, Sorensen HT, Gillman MW et al. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology 2000; 11: 185-8.
116. Litonjua AA, Carey VJ, Burge HA et al. Parental history and the risk for childhood asthma. Does mother confer more risk than father? Am J Respir Crit Care Med 1998; 158: 176-81.
117. Li YF, Gilliland FD, Berhane K et al. Effects of in utero and environmental tobacco smoke exposure on lung function in boys and girls with and without asthma. Am J Respir Crit Care Med 2000; 162: 2097-104.
118. Dejmek J, Solansky I, Podrazilova K, Sram RJ. The exposure of nonsmoking and smoking mothers to environmental tobacco smoke during different gestational phases and fetal growth. Environ Health Perspect 2002; 110: 601-6.
119. Gilliland FD, Berhane K, Li YF et al. Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function. Am J Respir Crit Care Med 2003; 167: 917-24.
120. Dold S, Wjst M, von Mutius E, Reitmeir P, Stiepel E. Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch Dis Child 1992; 67: 1018-22.
121. Longo G, Strinati R, Poli F, Fumi F. Genetic factors in nonspecific bronchial hyperreactivity. An epidemiologic study. Am J Dis Child 1987; 141: 331-4.
122. Greally M, Jagoe WS, Greally J. The genetics of asthma. Ir Med J 1982; 75: 403-5.
123. Van Arsdel PP Jr, Motulsky AG. Frequency and hereditability of asthma and allergic rhinitis in college students. Acta Genet Stat Med 1959; 9: 101-14.
124. Sibbald B, Horn ME, Brain EA, Gregg I. Genetic factors in childhood asthma. Thorax 1980; 35: 671-4.
125. Jenkins MA, Hopper JL, Giles GG. Regressive logistic modeling of familial aggregation for asthma in 7394 population-based nuclear families. Genet Epidemiol 1997; 14: 317-32.
126. Duffy DL, Martin NG, Battistutta D et al. Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 1990; 142: 1351-8.
127. Nieminen MM, Kaprio J, Koskenvuo M. A population-based study of bronchial asthma in adult twin pairs. Chest 1991; 100: 70-5.
128. Hopp RJ, Bewtra AK, Watt GD et al. Genetic analysis of allergic disease in twins. J Allergy Clin Immunol 1984; 73: 265-70.
129. Lubs ML. Emperic risks for genetic counseling in families with allergy. J Pediatr 1972; 80: 26-31.
130. Edfors-Lubs ML. Allergy in 7000 twin pairs. Acta Allergol 1971; 26: 249-85.
131. Sandford A, Weir T, Pare P. The genetics of asthma. Am J Respir Crit Care Med 1996; 153: 1749-65.
132. Konig P, Godfrey S. Exercise-induced bronchial lability and atopic status of families of infants with wheezy bronchitis. Arch Dis Child 1973; 48: 942-6.
133. Lewitter FI, Tager IB, McGue M et al. Genetic and environmental determinants of level of pulmonary function. Am J Epidemiol 1984; 120: 518-30.
134. Tager IB, Rosner B, Tishler PV et al. Household aggregation of pulmonary function and chronic bronchitis. Am Rev Respir Dis 1976; 114: 485-92.
135. Hankins D, Drage C, Zamel N, Kronenberg R. Pulmonary function in identical twins raised apart. Am Rev Respir Dis 1982; 125: 119-21.
136. Hubert HB, Fabsitz RR, Feinleib M, Gwinn C. Genetic and environmental influences on pulmonary function in adult twins. Am Rev Respir Dis 1982; 125: 409-15.
137. Redline S, Tishler PV, Rosner B et al. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol 1989; 129: 827-36.
138. Niu T, Rogus JJ, Chen C et al. Familial aggregation of bronchodilator response: a community-based study. Am J Respir Crit Care Med 2000; 162: 1833-7.
139. Daniels SE, Bhattacharrya S, James A et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996; 383: 247-50.
140. Bleecker ER, Postma DS, Howard TD et al. Genome screen for susceptibility loci in a genetically homogeneous Dutch population. Am J Respir Crit Care Med 1999; 159: A645 (Abstract).
141. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet 1997; 15: 389-92.
142. Ober C, Cox NJ, Abney M et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet 1998; 7: 1393-8.
143. Wjst M, Fischer G, Immervoll T et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics 1999; 58: 1-8.
144. Yokouchi Y, Nukaga Y, Shibasaki M et al. Significant evidence for linkage of mite-sensitive childhood asthma to chromosome 5q31-q33 near the interleukin 12 B locus by a genome-wide search in Japanese families. Genomics 2000; 66: 152-60.
145. Dizier MH, Besse-Schmittler C, Guilloud-Bataille M et al. Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med 2000; 162: 1812-8.
146. Laitinen T, Daly MJ, Rioux JD et al. A susceptibility locus for asthma-related traits on chromosome 7 revealed by genomewide scan in a founder population. Nat Genet 2001; 28: 87-91.
147. Xu X, Fang Z, Wang B et al. A genomewide search for quantitative-trait loci underlying asthma. Am J Hum Genet 2001; 69: 1271-7.
148. Haagerup A, Bjerke T, Schiotz PO et al. Asthma and atopy - a total genome scan for susceptibility genes. Allergy 2002; 57: 680-6.
149. Hakonarson H, Bjornsdottir US, Halapi E et al. A major susceptibility gene for asthma maps to chromosome 14q24. Am J Hum Genet 2002; 71: 483-91.
150. Huang SK, Mathias RA, Ehrlich E et al. Evidence for asthma susceptibility genes on chromosome 11 in an African-American population. Hum Genet 2003; 113: 71-5.
151. Xu J, Meyers DA, Ober C et al. Genomewide screen and identification of gene-gene interactions for asthmasusceptibility loci in three US populations: collaborative study on the genetics of asthma. Am J Hum Genet 2001; 68: 1437-46.
152. Mathias RA, Freidhoff LR, Blumenthal MN et al. Genome-wide linkage analyses of total serum IgE using variance components analysis in asthmatic families. Genet Epidemiol 2001; 20: 340-55.
153. Blumenthal MN, Langefeld CD, Beaty TH et al. A genome-wide search for allergic response (atopy) genes in three ethnic groups: Collaborative Study on the Genetics of Asthma. Hum Genet 2004; 114: 157-64.
154. Ober C, Tsalenko A, Willadsen S et al. Genome-wide screen for atopy susceptibility alleles in the Hutterites. Clin Exp Allergy 1999; 29: 11-5.
155. Koppelman GH, Stine OC, Xu J et al. Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol 2002; 109: 498-506.
156. Xu J, Postma DS, Howard TD et al. Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet 2000; 67: 1163-73.
157. Van Eerdewegh P, Little RD, Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002; 418: 426-30.
158. Daniels SE, Bhattacharrya S, James A et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996; 383: 247-50.
159. Lander E, Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-7.
160. Collaborative Study on the Genetics of Asthma. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997; 15: 389-392.
161. Xu J, Meyers DA, Ober C et al. Genomewide screen and identification of gene-gene interactions for asthmasusceptibility loci in three US populations: collaborative study on the genetics of asthma. Am J Hum Genet 2001; 68: 1437-46.
162. Mathias RA, Freidhoff LR, Blumenthal MN et al. Genome-wide linkage analyses of total serum IgE using variance components analysis in asthmatic families. Genet Epidemiol 2001; 20: 340-55.
163. Blumenthal MN, Ober C, Beaty TH et al. Genome scan for loci linked to mite sensitivity: the Collaborative Study on the Genetics of Asthma (CSGA). Genes Immun 2004; 5: 226-31.
164. Lander ES, Schork N. Genetic dissection of complex traits. Science 1994; 265: 2037-48.
165. Ober C, Tsalenko A, Parry R, Cox NJ. A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet 2000; 67: 1154-62.
166. Silverman EK, Palmer LJ. Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 2000; 22: 645-8.
167. Laitinen T, Polvi A, Rydman P et al. Characterization of a common susceptibility locus for asthma-related traits. Science 2004; 304: 300-4.
168. Zhang Y, Leaves NI, Anderson GG et al. Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat Genet 2003; 34: 181-6.
169. Allen M, Heinzmann A, Noguchi E et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet 2003; 35: 258-63.
170. DeSanctis GT, Merchant M, Beier DR et al. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat Genet 1995; 11: 150-154.
171. Howard TD, Postma DS, Jongepier H et al. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J Allergy Clin Immunol 2003; 112: 717-22.
172. Lind DL, Choudhry S, Ung N et al. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am J Respir Crit Care Med 2003; 168: 1312-6.
173. Raby BA, Silverman EK, Kwiatkowski DJ et al. ADAM33 polymorphisms and phenotype associations in childhood asthma. J Allergy Clin Immunol 2004; 113: 1071-8.
174. Qi SY, Riviere PJ, Trojnar J et al. Cloning and characterization of dipetidyl peptidase 10, a new member of an emerging subgroup of serine proteases. Biochem J 2003; 373: 179-189.
175. Scanlan MJ, Gordan JD, Williamson B et al. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 1999; 83: 456-64.
176. Hoffjan S, Nicolae D, Ober C. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res 2003; 4: 14.
177. Wahl SM, Vazquez N, Chen W. Regulatory T cells and transcription factors: gatekeepers in allergic inflammation. Curr Opin Immunol 2004; 16: 768-74.
178. Rosenwasser LJ, Klemm DJ, Dresback JK et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Aller 1995; 25(Suppl 2): 74-8; discussion 95-6.
179. Noguchi E, Shibasaki M, Arinami T et al. Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 1998; 28: 449-53.
180. Zhu S, Chan-Yeung M, Becker AB et al. Polymorphisms of the IL-4, TNF-alpha, and Fcepsilon RIbeta genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med 2000; 161: 1655-9.
181. Beghe B, Barton S, Rorke S et al. Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin Exp Allergy 2003; 33: 1111-7.
182. Kabesch M, Tzotcheva I, Carr D et al. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 2003; 112: 893-8.
183. Basehore MJ, Howard TD, Lange LA et al. A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J Allergy Clin Immunol 2004; 114: 80-7.
184. Tanaka K, Sugiura H, Uehara M et al. Lack of association between atopic eczema and the genetic variants of interleukin-4 and the interleukin-4 receptor alpha chain gene: heterogeneity of genetic backgrounds on immunoglobulin E production in atopic eczema patients. Clin Exp Allergy 2001; 31: 1522-7.
185. Sandford AJ, Chagani T, Zhu S et al. Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol 2000; 106: 135-40.
186. Burchard EG, Silverman EK, Rosenwasser LJ et al. Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. Am J Respir Crit Care Med 1999; 160: 919-22.
187. Novak N, Kruse S, Kraft S et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 2002; 119: 870-5.
188. Takabayashi A, Ihara K, Sasaki Y et al. Childhood atopic asthma: positive association with a polymorphism of IL-4 receptor alpha gene but not with that of IL-4 promoter or Fc epsilon receptor I beta gene. Exp Clin Immunogenet 2000; 17: 63-70.
189. Hakonarson H, Bjornsdottir US, Ostermann E et al. Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med 2001; 164: 2036-44.
190. Elliott K, Fitzpatrick E, Hill D et al. The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhood. J Allergy Clin Immunol 2001; 108: 285-7.
191. Howard TD, Koppelman GH, Zheng SL et al. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 2002; 70: 230-6.
192. Mitsuyasu H, Izuhara K, Mao XQ et al. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998; 19: 119-20.
193. Izuhara K, Yanagihara Y, Hamasaki N et al. Atopy and the human IL-4 receptor alpha chain. J Allergy Clin Immunol 2000; 106: S65-71.
194. Kruse S, Japha T, Tedner M et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999; 96: 365-71.
195. Noguchi E, Shibasaki M, Arinami T et al. No association between atopy/asthma and the ILe50Val polymorphism of IL- 4 receptor. Am J Respir Crit Care Med 1999; 160: 342-5.
196. Migliaccio C, Patuzzo C, Malerba G et al. No linkage or association of five polymorphisms in the interleukin-4 receptor alpha gene with atopic asthma in Italian families. Eur J Immunogenet 2003; 30: 349-53.
197. Tan EC, Lee BW, Chew FT et al. IL-4Ralpha gene Ile50Val polymorphism. Allergy 1999; 54: 1005-7.
198. Hytonen AM, Lowhagen O, Arvidsson M et al. Haplotypes of the interleukin-4 receptor alpha chain gene associate with susceptibility to and severity of atopic asthma. Clin Exp Allergy 2004; 34: 1570-5.
199. Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest 2004; 114: 1209-17.
200. Bourgain C, Hoffjan S, Nicolae R et al. Novel case-control test in a founder population identifies P-selectin as an atopysusceptibility locus. Am J Hum Genet 2003; 73: 612-26.
201. Hang LW, Hsia TC, Chen WC et al. Interleukin-10 gene -627 allele variants, not interleukin-I beta gene and receptor antagonist gene polymorphisms, are associated with atopic bronchial asthma. J Clin Lab Anal 2003; 17: 168-73.
202. Immervoll T, Loesgen S, Dutsch G et al. Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. Hum Mutat 2001; 18: 327-36.
203. Hobbs K, Negri J, Klinnert M et al. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998; 158: 1958-62.
204. Karjalainen J, Hulkkonen J, Nieminen MM et al. Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin Exp Allergy 2003; 33: 78-83.
205. Lyon H, Lange C, Lake S et al. IL10 gene polymorphisms are associated with asthma phenotypes in children. Genet Epidemiol 2004; 26: 155-65.
206. Unoki M, Furuta S, Onouchi Y et al. Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene. Hum Genet 2000; 106: 440-6.
207. Grunig G, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-3.
208. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immun 1998; 102: 165-9.
209. Chen W, Ericksen MB, Levin LS, Khurana Hershey GK. Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants. J Allergy Clin Immunol 2004; 114: 553-60.
210. van der Pouw Kraan TC, van Veen A, Boeije LC et al. An IL-13 promotor polymorphism associated with increased risk of allergic asthma. Genes Immun 1999; 1: 61-5.
211. Howard TD, Whittaker PA, Zaiman AL et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001; 25: 377-84.
212. Heinzmann A, Jerkic SP, Ganter K et al. Association study of the IL13 variant Arg110Gln in atopic diseases and juvenile idiopathic arthritis. J Allergy Clin Immunol 2003; 112: 735-9.
213. Heinzmann A, Mao XQ, Akaiwa M et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000; 9: 549-59.
214. Liu X, Nickel R, Beyer K et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol 2000; 106: 167-70.
215. Leung TF, Tang NL, Chan IH et al. A polymorphism in the coding region of interleukin-13 gene is associated with atopy but not asthma in Chinese children. Clin Exp Allergy 2001; 31: 1515-21.
216. Tsunemi Y, Saeki H, Nakamura K et al. Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci 2002; 30: 100-7.
217. DeMeo DL, Lange C, Silverman EK et al. Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet Epidemiol 2002; 23: 335-48.
218. Liu X, Beaty TH, Deindl P et al. Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immunol 2004; 113: 489-95.
219. Liu X, Beaty TH, Deindl P et al. Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immunol 2003; 112: 382-8.
220. Hummelshoj T, Bodtger U, Datta P et al. Association between an interleukin-13 promoter polymorphism and atopy. Eur J Immunogenet 2003; 30: 355-9.
221. Wang M, Xing ZM, Lu C et al. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet 2003; 113: 387-90.
222. Graves PE, Kabesch M, Halonen M et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000; 105: 506-13.
223. He JQ, Chan-Yeung M, Becker AB et al. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun 2003; 4: 385-9.
224. Celedón JC, Soto-Quiros ME, Palmer LJ et al. Lack of association between a polymorphism in the IL-13 gene and total serum IgE among nuclear families in Costa Rica. Clin Exp Allergy 2002; 32: 387-90.
225. Szentivayni A. The -adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 1968; 42: 203-232.
226. Kobilka BK, Dixon RA, Frielle T et al. cDNA for the human beta 2-adrenergic receptor: a protein with multiple membranespanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 1987; 84: 46-50.
227. Strader CD, Candelore MR, Hill WS et al. A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists. J Biol Chem 1989; 264: 16470-7.
228. Dixon RA, Sigal IS, Candelore MR et al. Structural features required for ligand binding to the beta-adrenergic receptor. EMBO J 1987; 6: 3269-75.
229. Rands E, Candelore MR, Cheung AH et al. Mutational analysis of beta-adrenergic receptor glycosylation. J Biol Chem 1990; 265: 10759-64.
230. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334-9.
231. McGraw DW, Forbes SL, Kramer LA, Liggett SB. Polymorphisms of the 5_ leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 1998; 102: 1927-32.
232. Parola AL, Kobilka BK. The peptide product of a 5_ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J Biol Chem 1994; 269: 4497-505.
233. Drysdale C, McGraw D, Stack C et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97: 10483-8.
234. Green SA, Cole G, Jacinto M et al. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993; 268: 23116-21.
235. Green SA, Rathz DA, Schuster AJ, Liggett SB. The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s). Eur J Pharmacol 2001; 421: 141-7.
236. Turki J, Lorenz JN, Green SA et al. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10483-8.
237. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33: 9414-9.
238. Green SA, Turki J, Bejarano P et al. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13: 25-33.
239. Moore PE, Laporte JD, Abraham JH et al. Polymorphism of the beta(2)-adrenergic receptor gene and desensitization in human airway smooth muscle. Am J Respir Crit Care Med 2000; 162: 2117-24.
240. Hopes E, McDougall C, Christie G et al. Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study. Br Med J 1998; 316: 664.
241. Santillan AA, Camargo CA Jr, Ramirez-Rivera A et al. Association between beta2-adrenoceptor polymorphisms and asthma diagnosis among Mexican adults. J Allergy Clin Immunol 2003; 112: 1095-100.
242. Silverman EK, Kwiatkowski DJ, Sylvia JS et al. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. J Allergy Clin Immunol 2003; 112: 870-6.
243. Summerhill E, Leavitt SA, Gidley H et al. Beta(2)-adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites. Am J Respir Crit Care Med 2000; 162: 599-602.
244. Dewar JC, Wheatley AP, Venn A et al. Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clin Exp Allergy 1998; 28: 442-8.
245. Wang Z, Chen C, Niu T et al. Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking. Am J Respir Crit Care Med 2001; 163: 1404-9.
246. Martinez FD, Graves PE, Baldini M et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100: 3184-8.
247. Ramsay CE, Hayden CM, Tiller KJ et al. Polymorphisms in the beta2-adrenoreceptor gene are associated with decreased airway responsiveness. Clin Exp Allergy 1999; 29: 1195-203.
248. Turki J, Pak J, Green SA et al. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95: 1635-41.
249. Holloway JW, Dunbar PR, Riley GA et al. Association of beta2- adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy 2000; 30: 1097-103.
250. Binaei S, Christensen M, Murphy C et al. Beta2-adrenergic receptor polymorphisms in children with status asthmaticus. Chest 2003; 123: 375S.
251. Kotani Y, Nishimura Y, Maeda H, Yokoyama M. Beta2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics. J Asthma 1999; 36: 583-90.
252. Kim SH, Oh SY, Oh HB et al. Association of beta2- adrenoreceptor polymorphisms with nocturnal cough among atopic subjects but not with atopy and nonspecific bronchial hyperresponsiveness. J Allergy Clin Immunol 2002; 109: 630-5.
253. Weir TD, Mallek N, Sandford AJ et al. Beta2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998; 158: 787-91.
254. Hall IP, Wheatley A, Wilding P, Liggett SB. Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995; 345: 1213-4.
255. D’Amato M, Vitiani LR, Petrelli G et al. Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med 1998; 158: 1968-73.
256. Ulbrecht M, Hergeth MT, Wjst M et al. Association of beta(2)- adrenoreceptor variants with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 161: 469-74.
257. Dewar JC, Wilkinson J, Wheatley A et al. The glutamine 27 B2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Aller Clin Immun 1997; 100: 261-5.
258. Tan S, Hall IP, Dewar J et al. Association between B2- adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 1997; 350: 995-9.
259. Martinez FD, Graves PE, Baldini M et al. Association between genetic polymorphisms of the B2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100: 3184-8.
260. Drysdale CM, McGraw DW, Stack CB et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97: 10483-8.
261. Israel E, Drazen JM, Liggett SB et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; 162: 75-80.
262. Deichmann KA, Schmidt A, Heinzmann A et al. Association studies on beta2-adrenoceptor polymorphisms and enhanced IgE responsiveness in an atopic population. Clin Exp Allergy 1999; 29: 794-9.
263. Lipworth BJ, Hall IP, Aziz I et al. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy. Clin Sci (Lond) 1999; 96: 253-9.
264. Guerra S, Lohman IC, Halonen M et al. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med 2004; 169: 70-6.
265. Baldini M, Lohman IC, Halonen M et al. A polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20: 976-83.
266. Koppelman GH, Reijmerink NE, Colin Stine O et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 2001; 163: 965-9.
267. Leung TF, Tang NL, Sung YM et al. The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol 2003; 14: 255-60.
268. Gao PS, Mao XQ, Kawai M et al. Lack of association between ACE gene polymorphisms and atopy and asthma in British and Japanese populations. Clin Genet 1998; 54: 245-7.
269. O’Donnell AR, Toelle BG, Marks GB et al. Age-specific relationship between CD14 and atopy in a cohort assessed from age 8 to 25 years. Am J Respir Crit Care Med 2004; 169: 615-22.
270. Buckova D, Holla LI, Schuller M et al. Two CD14 promoter polymorphisms and atopic phenotypes in Czech patients with IgE-mediated allergy. Allergy 2003; 58: 1023-6.
271. Cardaba B, Moffatt MF, Fernandez E et al. Allergy to dermatophagoides in a group of Spanish gypsies: genetic restrictions. Int Arch Allergy Immunol 2001; 125: 297-306.
272. Sengler C, Haider A, Sommerfeld C et al. Evaluation of the CD14 C-159 T polymorphism in the German Multicenter Allergy Study cohort. Clin Exp Allergy 2003; 33: 166-9.
273. Moffatt MF, Cookson WO. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 1997; 6: 551-4.
274. Albuquerque RV, Hayden CM, Palmer LJ et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy 1998; 28: 578-84.
275. Chagani T, Pare PD, Zhu S et al. Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am J Respir Crit Care Med 1999; 160: 278-82.
276. Winchester EC, Millwood IY, Rand L et al. Association of the TNF-alpha-308 (G7A) polymorphism with self-reported history of childhood asthma. Hum Genet 2000; 107: 591-6.
277. Witte JS, Palmer LJ, O’Connor RD et al. Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma. Eur J Hum Genet 2002; 10: 82-5.
278. Wang TN, Chen WY, Wang TH et al. Gene-gene synergistic effect on atopic asthma: tumour necrosis factor-alpha-308 and lymphotoxin-alpha-NcoI in Taiwan’s children. Clin Exp Allergy 2004; 34: 184-8.
279. Shin HD, Park BL, Kim LH et al. Association of tumor necrosis factor polymorphisms with asthma and serum total IgE. Hum Mol Genet 2004; 13: 397-403.
280. Li Kam Wa TC, Mansur AH, Britton J et al. Association between -308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy 1999; 29: 1204-8.
281. Castro J, Telleria JJ, Linares P, Blanco-Quiros A. Increased TNFA*2, but not TNFB*1, allele frequency in Spanish atopic patients. J Investig Allergol Clin Immunol 2000; 10: 149-54.
282. Trabetti E, Patuzzo C, Malerba G et al. Association of a lymphotoxin alpha gene polymorphism and atopy in Italian families. J Med Genet 1999; 36: 323-5.
283. Tan EC, Lee BW, Tay AW et al. Asthma and TNF variants in Chinese and Malays. Allergy 1999; 54: 402-3.
284. Malerba G, Trabetti E, Patuzzo C et al. Candidate genes and a genome-wide search in Italian families with atopic asthmatic children. Clin Exp Allergy 1999; 29(Suppl 4): 27-30.
285. Louis R, Leyder E, Malaise M et al. Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene. Eur Respir J 2000; 16: 604-8.
286. El Bahlawan L, Christensen M, Binaei S et al. Lack of association between the tumor necrosis factor-alpha regulatory region genetic polymorphisms associated with elevated tumor necrosis factor-alpha levels and children with asthma. Chest 2003; 123: 374S-5S.
287. Buckova D, Holla LI, Vasku A et al. Lack of association between atopic asthma and the tumor necrosis factor alpha-308 gene polymorphism in a Czech population. J Invest Allerg Clin Immunol 2002; 12: 192-7.
288. Moffatt MF, James A, Ryan G et al. Extended tumour necrosis factor/HLA-DR haplotypes and asthma in an Australian population sample. Thorax 1999; 54: 757-61.
289. Lin YC, Lu CC, Su HJ et al. The association between tumor necrosis factor, HLA-DR alleles, and IgE-mediated asthma in Taiwanese adolescents. Allergy 2002; 57: 831-4.
290. Izakovicova Holla L, Vasku A, Izakovic V, Znojil V. The interaction of the polymorphisms in transporter of antigen peptides (TAP) and lymphotoxin alpha (LT-alpha) genes and atopic diseases in the Czech population. Clin Exp Allergy 2001; 31: 1418-23.
291. Ansari AA, Freidhoff LR, Meyers DA et al. Human immune responsiveness to Lolium perenne pollen allergen Lol p III (rye III) is associated with HLA-DR3 and DR5. Hum Immunol 1989; 25: 59-71.
292. Fischer GF, Pickl WF, Fae I et al. Association between IgE response against Bet v I, the major allergen of birch pollen, and HLA-DRB alleles. Hum Immunol 1992; 33: 259-65.
293. D’Amato M, Scotto d’Abusco A, Maggi E et al. Association of responsiveness to the major pollen allergen of Parietaria officinalis with HLA-DRB1* alleles: a multicenter study. Hum Immun 1996; 46: 100-6.
294. Stephan V, Kuehr J, Seibt A et al. Genetic linkage of HLA-class II locus to mite-specific IgE immune responsiveness. Clin Exp Allergy 1999; 29: 1049-54.
295. Donfack J, Tsalenko A, Hoki DM et al. HLA-DRB1*01 alleles are associated with sensitization to cockroach allergens. J Aller Clin Immun 2000; 105: 960-6.
296. Hu C, Hsu PN, Lin RH et al. HLA DPB1*0201 allele is negatively associated with immunoglobulin E responsiveness specific for house dust mite allergens in Taiwan. Clin Exp Allergy 2000; 30: 538-45.
297. Moffatt MF, Schou C, Faux JA et al. Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample. Eur J Hum Genet 2001; 9: 341-6.
298. Kim YK, Oh HB, Oh SY et al. HLA-DRB1*07 may have a susceptibility and DRB1*04 a protective effect upon the development of a sensitization to house dust mite Dermatophagoides pteronyssinus. Clin Exp Allergy 2001; 31: 110-5.
299. Moffatt MF, Faux JA, Lester S et al. Atopy, respiratory function and HLA-DR in Aboriginal Australians. Hum Mol Genet 2003; 12: 625-30.
300. Marsh DG, Hsu SH, Roebber M et al. HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Med 1982; 155: 1439-51.
301. Marsh DG, Freidhoff LR, Ehrlich-Kautzky E et al. Immune responsiveness to Ambrosia artemisiifolia (short ragweed) pollen allergen Amb a VI (Ra6) is associated with HLA-DR5 in allergic humans. Immunogenetics 1987; 26: 230-6.
302. Freidhoff LR, Ehrlich-Kautzky E, Meyers DA et al. Association of HLA-DR3 with human immune response to Lol p I and Lol p II allergens in allergic subjects. Tissue Antigens 1988; 31: 211-9.
303. Cardaba B, Vilches C, Martin E et al. DR7 and DQ2 are positively associated with immunoglobulin-E response to the main antigen of olive pollen (Ole e I) in allergic patients. Hum Immunol 1993; 38: 293-9.
304. Kalpaklioglu AF, Turan M. Possible association between cockroach allergy and HLA class II antigens. Ann Allergy Asthma Immunol 2002; 89: 155-8.
305. Aron Y, Desmazes-Dufeu N, Matran R et al. Evidence of a strong positive association between atopy and the HLA class II alleles DR4 and DR7. Clin Exp Allergy 1996; 26: 821-826.
306. Di Somma C, Charron D, Deichmann K et al. Atopic asthma and TNF-308 alleles: linkage disequilibrium and association analyses. Hum Immunol 2003; 64: 359-65.
307. Howell WM, Standring P, Warner JA, Warner JO. HLA class II genotype, HLA-DR B cell surface expression and allergen specific IgE production in atopic and non-atopic members of asthmatic family pedigrees. Clin Exp Allergy 1999; 29 (Suppl 4): 35-8.
308. Woszczek G, Kowalski ML, Borowiec M. Association of asthma and total IgE levels with human leucocyte antigen-DR in patients with grass allergy. Eur Respir J 2002; 20: 79-85.
309. Holloway JW, Doull I, Begishvili B et al. Lack of evidence of a significant association between HLA-DR, DQ and DP genotypes and atopy in families with HDM allergy. Clin Exp Allergy 1996; 26: 1142-9.
310. Dekker JW, Nizankowska E, Schmitz-Schumann M et al. Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy 1997; 27: 574-7.
311. Young RP, Dekker JW, Wordsworth BP et al. HLA-DR and HLADP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994; 24: 431-9.
312. Sandford AJ, Shirakawa T, Moffatt MF et al. Localisation of atopy and beta subunit of high-affinity IgE receptor (Fc epsilon RI) on chromosome 11q. Lancet 1993; 341: 332-4.
313. Szepetowski P, Gaudray P. FCER1B, a candidate gene for atopy, is located in 11q13 between CD20 and TCN1. Genomics 1994; 19: 399-400.
314. Kuster H, Zhang L, Brini AT et al. The gene and cDNA for the human high affinity immunoglobulin E receptor beta chain and expression of the complete human receptor. J Biol Chem 1992; 267: 12782-7.
315. Cookson WO, Sharp PA, Faux JA, Hopkin JM. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989; 1: 1292-5.
316. Young RP, Sharp PA, Lynch JR et al. Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J Med Genet 1992; 29: 236-8.
317. The Collaborative Study on the Genetics of Asthma. A genomewide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet 1997; 15: 389-92.
318. Daniels S, Bhattacharrya S, James A et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996; 383: 247-50.
319. Shirakawa T, Li A, Dubowitz M et al. Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor. Nat Genet 1994; 7: 125-9.
320. Folster-Holst R, Moises HW, Yang L et al. Linkage between atopy and the IgE high-affinity receptor gene at 11q13 in atopic dermatitis families. Hum Genet 1998; 102: 236-9.
321. van Herwerden L, Harrap SB, Wong ZY et al. Linkage of highaffinity IgE receptor gene with bronchial hyperreactivity, even in absence of atopy. Lancet 1995; 346: 1262-5.
322. Trabetti E, Cusin V, Malerba G et al. Association of the FcepsilonRIbeta gene with bronchial hyper-responsiveness in an Italian population. J Med Genet 1998; 35: 680-1.
323. Hizawa N, Yamaguchi E, Ohe M et al. Lack of linkage between atopy and locus 11q13. Clin Exp Allergy 1992; 22: 1065-9.
324. Rich SS, Roitman-Johnson B, Greenberg B et al. Genetic analysis of atopy in three large kindreds: no evidence of linkage to D11S97. Clin Exp Allergy 1992; 22: 1070-6.
325. Amelung PJ, Panhuysen CI, Postma DS et al. Atopy and bronchial hyperresponsiveness: exclusion of linkage to markers on chromosomes 11q and 6p. Clin Exp Allergy 1992; 22: 1077-84.
326. Lympany P, Welsh KI, Cochrane GM et al. Genetic analysis of the linkage between chromosome 11q and atopy. Clin Exp Allergy 1992; 22: 1085-92.
327. Simon Thomas N, Wilkinson J, Lonjou C et al. Linkage analysis of markers on chromosome 11q13 with asthma and atopy in a United Kingdom population. Am J Respir Crit Care Med 2000; 162: 1268-72.
328. Ishizaka K, Ishizaka T. Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gammaA- or gammaG-globulin. J Allergy 1966; 37: 169-85.
329. Lin S, Cicala C, Scharenberg AM, Kinet JP. The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgammamediated cell activation signals. Cell 1996; 85: 985-95.
330. Donnadieu E, Jouvin MH, Kinet JP. A second amplifier function for the allergy-associated Fc(epsilon)RI-beta subunit. Immunity 2000; 12: 515-23.
331. Saini SS, Richardson JJ, Wofsy C et al. Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils. J Allergy Clin Immunol 2001; 107: 832-41.
332. Hill MR, Cookson WO. A new variant of the beta subunit of the high-affinity receptor for immunoglobulin E (Fc epsilon RI-beta E237G): associations with measures of atopy and bronchial hyper-responsiveness. Hum Mol Genet 1996; 5: 959-62.
333. Shirakawa T, Mao XQ, Sasaki S et al. Association between Fc epsilon RI beta and atopic disorder in a Japanese population. Lancet 1996; 347: 394-5.
334. Nagata H, Mutoh H, Kumahara K et al. Association between nasal allergy and a coding variant of the Fc epsilon RI beta gene Glu237Gly in a Japanese population. Hum Genet 2001; 109: 262-6.
335. Dickson PW, Wong ZY, Harrap SB et al. Mutational analysis of the high affinity immunoglobulin E receptor beta subunit gene in asthma. Thorax 1999; 54: 409-12.
336. Hizawa N, Yamaguchi E, Furuya K et al. Association between high serum total IgE levels and D11S97 on chromosome 11q13 in Japanese subjects. J Med Genet 1995; 32: 363-9.
337. Rohrbach M, Kraemer R, Liechti-Gallati S. Screening of the Fc epsilon RI-beta-gene in a Swiss population of asthmatic children: no association with E237G and identification of new sequence variations. Dis Markers 1998; 14: 177-86.
338. Palmer LJ, Rye PJ, Gibson NA et al. Association of FcepsilonR1- beta polymorphisms with asthma and associated traits in Australian asthmatic families. Clin Exp Allergy 1999; 29: 1555-62.
339. Green SL, Gaillard MC, Song E et al. Polymorphisms of the beta chain of the high-affinity immunoglobulin E receptor (Fcepsilon RI-beta) in South African black and white asthmatic and nonasthmatic individuals. Am J Respir Crit Care Med 1998; 158: 1487-92.
340. Donnadieu E, Cookson WO, Jouvin MH, Kinet JP. Allergyassociated polymorphisms of the Fc epsilon RI beta subunit do not impact its two amplification functions. J Immunol 2000; 165: 3917-22.
341. Furumoto Y, Hiraoka S, Kawamoto K et al. Polymorphisms in FcepsilonRI beta chain do not affect IgE-mediated mast cell activation. Biochem Biophys Res Commun 2000; 273: 765-71.
342. Palmer LJ, Pare PD, Faux JA et al. Fc epsilon R1-beta polymorphism and total serum IgE levels in endemically parasitized Australian aborigines. Am J Hum Genet 1997; 61: 182-8.
343. van Hage-Hamsten M, Johansson E, Kronqvist M et al. Associations of Fc epsilon R1-beta polymorphisms with immunoglobin E antibody responses to common inhalant allergens in a rural population. Clin Exp Allergy 2002; 32: 838-42.
344. Traherne JA, Hill MR, Hysi P et al. LD mapping of maternally and non-maternally derived alleles and atopy in FcepsilonRIbeta. Hum Mol Genet 2003; 12: 2577-85.
345. Moffatt MF, Cookson WO. The genetics of asthma. Maternal effects in atopic disease. Clin Exp Allergy 1998; 28(Suppl 1): 56-61; discussion 65-6.
346. Kuehr J, Karmaus W, Forster J et al. Sensitization to four common inhalant allergens within 302 nuclear families. Clin Exp Allergy 1993; 23: 600-5.
347. Bray GW. The heredity factor in hypersensitiveness, anaphylaxis and allergy. J Allergy 1931; 2: 203-4.
348. Collee JM, ten Kate LP, de Vries HG et al. Allele sharing on chromosome 11q13 in sibs with asthma and atopy. Lancet 1993; 342: 936.
349. Deichmann KA, Starke B, Schlenther S et al. Linkage and association studies of atopy and the chromosome 11q13 region. J Med Genet 1999; 36: 379-82.
350. Cox HE, Moffatt MF, Faux JA et al. Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br J Dermatol 1998; 138: 182-7.
351. Matsuoka T, Hirata M, Tanaka H et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000; 287: 2013-7.
352. Oguma T, Palmer LJ, Birben E et al. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med 2004; 351: 1752-63.
353. Tomkinson A, Cieslewicz G, Duez C et al. Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice. Am J Respir Crit Care Med 2001; 163: 721-30.
354. Takeda K, Hamelmann E, Joetham A et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997; 186: 449-54.
355. Wills-Karp M. Murine models of asthma in understanding immune dysregulation in human asthma. Immunopharmacology 2000; 48: 263-8.
356. Henderson WR Jr, Tang LO, Chu SJ et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002; 165: 108-16.
357. Erjefalt JS, Greiff L, Andersson M et al. Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease. Thorax 2001; 56: 341-4.
358. Levitt RC, Mitzner W. Autosomal recessive inheritance of airway hyperreactivity to 5-hydroxytryptamine. J Appl Physiol 1989; 67: 1125-32.
359. De Sanctis GT, Merchant M, Beier DR et al. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat Genet 1995; 11: 150-4.
360. Ewart SL, Mitzner W, DiSilvestre DA et al. Airway hyperresponsiveness to acetylcholine: segregation analysis and evidence for linkage to murine chromosome 6. Am J Respir Cell Mol Biol 1996; 14: 487-95.
361. De Sanctis GT, Drazen JM. Genetics of native airway responsiveness in mice. Am J Respir Crit Care Med 1997; 156: S82-8.
362. Wills-Karp M, Ewart SL. The genetics of allergen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1997; 156: S89-96.
363. Whitehead GS, Walker JK, Berman KG et al. Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol 2003; 285: L32-42.
364. Shinagawa K, Kojima M. Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med 2003; 168: 959-67.
365. Levitt RC, Mitzner W. Expression of airway hyperreactivity to acetylcholine as a simple autosomal recessive trait in mice. FASEB J 1988; 2: 2605-8.
366. Levitt RC, Mitzner W, Kleeberger SR. A genetic approach to the study of lung physiology: understanding biological variability in airway responsiveness. Am J Physiol 1990; 258: L157-64.
367. Longphre M, Kleeberger SR. Susceptibility to platelet-activating factor-induced airway hyperreactivity and hyperpermeability: interstrain variation and genetic control. Am J Respir Cell Mol Biol 1995; 13: 586-94.
368. Konno S, Adachi M, Matsuura T et al. Bronchial reactivity to methacholine and serotonin in six inbred mouse strains. Arerugi 1993; 42: 42-7.
369. Levitt RC, Ewart SL. Genetic susceptibility to atracurium-induced bronchoconstriction. Am J Respir Crit Care Med 1995; 151: 1537-42.
370. Duguet A, Biyah K, Minshall E et al. Bronchial responsiveness among inbred mouse strains. Role of airway smooth-muscle shortening velocity. Am J Respir Crit Care Med 2000; 161: 839-48.
371. De Sanctis GT, Singer JB, Jiao A et al. Quantitative trait locus mapping of airway responsiveness to chromosomes 6 and 7 in inbred mice. Am J Physiol 1999; 277: L1118-23.
372. Ewart SL, Kuperman D, Schadt E et al. Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am J Respir Cell Mol Biol 2000; 23: 537-545.
373. Brewer JP, Kisselgof AB, Martin TR. Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med 1999; 160: 1150-6.
374. Takeda K, Haczku A, Lee JJ et al. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol 2001; 281: L394-402.
375. Wilder JA, Collie DD, Wilson BS et al. Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. Am J Respir Cell Mol Biol 1999; 20: 1326-34.
376. Larsen GL, Renz H, Loader JE et al. Airway response to electrical field stimulation in sensitized inbred mice. Passive transfer of increased responsiveness with peribronchial lymph nodes. J Clin Invest 1992; 89: 747-52.
377. Levitt RC, Eleff SM, Zhang LY et al. Linkage homology for bronchial hyperresponsiveness between DNA markers on human chromosome 5q31-q33 and mouse chromosome 13. Clin Exp Allergy 1995; 25(Suppl 2): 61-3.
378. Zhang Y, Lefort J, Kearsey V et al. A genome-wide screen for asthma-associated quantitative trait loci in a mouse model of allergic asthma. Hum Mol Genet 1999; 8: 601-5.
379. The Collaborative Study on the Genetics of Asthma (CSGA). A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997; 15: 389-92.
380. Ober C, Cox NJ, Abney M et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet 1998; 7: 1393-8.
381. Wjst M, Fischer G, Immervoll T et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics 1999; 58: 1-8.
382. Leaves NI, Bhattacharyya S, Wiltshire S, Cookson WO. A detailed genetic map of the chromosome 7 bronchial hyperresponsiveness locus. Eur J Hum Genet 2002; 10: 177-82.
383. Noguchi E, Yokouchi Y, Shibasaki M et al. Association between TNFA polymorphism and the development of asthma in the Japanese population. Am J Respir Crit Care Med 2002; 166: 43-6.
384. Herbon N, Werner M, Braig C et al. High-resolution SNP scan of chromosome 6p21 in pooled samples from patients with complex diseases. Genomics 2003; 81: 510-8.
385. Raby BA, Silverman EK, Lazarus R et al. Chromosome 12q harbors multiple genetic loci related to asthma and asthmarelated phenotypes. Hum Mol Genet 2003; 12: 1973-9.
386. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Ann Rev Immunol 2003; 21: 713-758.
387. D’Ambrosio D, Cippitelli M, Cocciolo MG et al. Inhibition of IL-12 production by 1, 25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998; 101: 252-62.
388. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1, 25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995; 125: 1704S-8S.
389. O’Kelly J, Hisatake J, Hisatake Y et al. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J Clin Invest 2002; 109: 1091-9.
390. Matheu V, Back O, Mondoc E, Issazadeh-Navikas S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J Allergy Clin Immunol 2003; 112: 585-92.
391. Nakao F, Ihara K, Kusuhara K et al. Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J Allergy Clin Immunol 2001; 107: 499-504.
392. Ober C, Tsalenko A, Parry R, Cox NJ. A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet 2000; 67: 1154-62.
393. Poon AH, Laprise C, Lemire M et al. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med 2004; 170: 967-73.
394. Raby BA, Lazarus R, Silverman EK et al. Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am J Respir Crit Care Med 2004; 170: 1057-65.
395. McIntire JJ, Umetsu SE, Akbari O et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2001; 2: 1109-16.
396. Matricardi PM, Rosmini F, Panetta V et al. Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 2002; 110: 381-7.
397. McIntire JJ, Umetsu SE, Macaubas C et al. Immunology: hepatitis A virus link to atopic disease. Nature 2003; 425: 576.
398. Symula DJ, Frazer KA, Ueda Y et al. Functional screening of an asthma QTL in YAC transgenic mice. Nat Genet 1999; 23: 241-4.
399. Zhu Z, Homer RJ, Wang Z et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779-88.
400. Kauppi P, Lindblad-Toh K, Sevon P et al. A second-generation association study of the 5q31 cytokine gene cluster and the interleukin-4 receptor in asthma. Genomics 2001; 77: 35-42.
401. Karp CL, Grupe A, Schadt E et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol 2000; 1: 221-6.
402. Krug N, Tschernig T, Erpenbeck VJ et al. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med 2001; 164: 1841-3.
403. Hasegawa K, Tamari M, Shao C et al. Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma. Hum Genet 2004; 115: 295-301. The following references are duplicated: 141/160/317/319, 61/144, 139/158/318, 151/161, 60/155, 142/380, and 165/392.